Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: BIOKIN PHARMACEUTICAL(688506) the Revenue is 92.75 M (-10.61%);the EBIT is -859.01 M (-38.54%);the EPS is -2.09 (-43.17%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.09B10.61%
----
----
EBIT
-0.86B38.54%
----
----
EPS
-2.089843.17%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf